One-year results from the first US-based enhanced recovery after cardiac surgery (ERAS Cardiac) program.
Analgesics, Opioid
/ administration & dosage
Attitude of Health Personnel
Cardiac Surgical Procedures
/ adverse effects
Delivery of Health Care, Integrated
Diet, Carbohydrate Loading
Humans
Hypoglycemic Agents
/ administration & dosage
Insulin
/ administration & dosage
Length of Stay
Pain Management
Patient Satisfaction
Perioperative Care
/ adverse effects
Postoperative Complications
/ etiology
Program Development
Program Evaluation
Prospective Studies
Recovery of Function
Risk Factors
Time Factors
Treatment Outcome
United States
cardiac surgery
complications
enhanced recovery
outcomes
perioperative care
value
Journal
The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
27
04
2018
revised:
25
10
2018
accepted:
28
10
2018
pubmed:
23
1
2019
medline:
25
2
2020
entrez:
23
1
2019
Statut:
ppublish
Résumé
Our enhanced recovery after cardiac surgery (ERAS Cardiac) program is an evidence-based interdisciplinary process, which has not previously been systematically applied to cardiac surgery in the United States. The Knowledge-to-Action Framework synthesized evidence-based enhanced recovery interventions and implementation of a designated ERAS Cardiac program. Standardized processes included (1) preoperative patient education, (2) carbohydrate loading 2 hours before general anesthesia, (3) multimodal opioid-sparing analgesia, (4) goal-directed perioperative insulin infusion, and (5) a rigorous bowel regimen. All cardiac anesthesiologists and surgeons agreed to follow the standardized pathway for adult cardiac surgery cases. The 1-year outcomes were compared between the 9 months pre- and post-ERAS Cardiac implementation using prospectively collected, retrospectively reviewed data. Comparing the pre- (N = 489) with the post- (N = 443) ERAS Cardiac groups, median postoperative length of stay was decreased from 7 to 6 days (P < .01). Total intensive care unit hours were decreased from a mean of 43 to 28 hours (P < .01). The incidence of gastrointestinal complications was 6.8% pre-ERAS versus 3.6% post-ERAS implementation (P < .05). Opioid use was reduced by a mean of 8 mg of morphine equivalents per patient in the first 24 hours postoperatively (P < .01). Reintubation rate and intensive care unit readmission rate were reduced by 1.2% and 1.5%, respectively (P = not significant). The incidence of hyperglycemic episodes was no different after ERAS Cardiac initiation. Patient satisfaction was 86.3% pre-ERAS versus 91.8% post-ERAS Cardiac implementation and work culture domain scores revealed increases in satisfaction across all measured indices, including patient focus, culture, and engagement. Initial clinical and survey data after the first year of a system-wide ERAS Cardiac program were associated with significantly improved perioperative outcomes. We believe this value-based approach to cardiac surgery can consistently result in earlier recovery, cost reductions, and increased patient/staff satisfaction.
Identifiants
pubmed: 30665758
pii: S0022-5223(18)33225-2
doi: 10.1016/j.jtcvs.2018.10.164
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Hypoglycemic Agents
0
Insulin
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1881-1888Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.